ClinicalTrials.gg
RecruitingNCT05305430Updated May 8, 2026

Real World Data Collection on the Synergy Cervical Disc

An observational study in Cervical Disc Degeneration, sponsored by Synergy Spine Solutions. Recruiting at 1 site in Australia. Open to participants aged 21 Years and older. Per ClinicalTrials.gov, last updated 2026-05-08.

Sponsored by Synergy Spine Solutions · Observational

From the registry’s dates

  • Started May 2022; still recruiting 4 years 6 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
200
Ages
21 Years and older
Sex
All
01

Study summary

This trial is a real world data (RWD) collection observational study, comprised of both prospective and retrospective arms, that will examine the safety and effectiveness of the Synergy Cervical Disc System in patients with degenerative cervical disc disease.

02

Conditions studied

  • Cervical Disc Degeneration

Keywords

  • degenerative disc
  • cervical
  • radiculopathy
  • myelopathy
  • motion preservation
03

In context

Radiculopathy

483 studies on the registry are indexed under Radiculopathy; 145 are open to participants now.

This study's planned enrollment of 200 is above the median of 100 across 95 observational studies indexed under Radiculopathy.

Browse Radiculopathy studies →

Lead sponsor

Synergy Spine Solutions is the lead sponsor of 7 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Both retrospective and prospective study subjects that have cervical degenerative disc disease requiring treatment with the Synergy Spine Solutions Synergy Disc.

Prospective study cohort: All patients for whom it has been decided that the Synergy Spine Solutions Synergy Disc will be implanted at participating investigative centers and give informed consent to participate in the prospective segment of this protocol.

Retrospective study cohort: Patients who have previously had a Synergy Spine Solutions Synergy Disc implanted. If required by local regulations, informed consent will be sought and received from the participating patient prior to data collection from the medical records per country-specific regulations.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Over the age of 21 at the time of the surgery.
  2. Have had (retrospective cohort) or the decision has been made to have (prospective cohort) the Synergy Disc implanted
  3. Skeletally mature patients for reconstruction of the disc from C3-C7 following a single or multiple level discectomy for intractable radiculopathy
  4. Intractable radiculopathy and/or myelopathy with at least one of the following producing symptomatic nerve root and/or spinal cord compression: herniated disc and/or osteophyte formation
  5. Symptomatic nerve root and/or spinal cord compression documented by patient history (arm or neck pain and/or neurologic deficit) and imaging (CT, MRI, x-rays, etc.)
  6. Failed a minimum of 6 weeks conservative treatment
  7. Written given by subject, as applicable.

Exclusion criteria

Exclusion Criteria:

  1. Moderate to advanced spondylosis
  2. Diagnosis of osteoporosis
  3. Active systemic infection or infection at the operative site
  4. Pregnancy
  5. Marked cervical instability on lateral, coronal, or flexion/extension radiographs
  6. Cervical spine condition other than symptomatic cervical disc disease requiring surgical treatment at the involved level
  7. Severe pathology of the facet joints of the involved vertebral bodies
  8. Previous diagnosis of osteopenia or osteomalacia
  9. More than one immobile vertebral level between C1 and T1 from any cause
  10. Morbid obesity
  11. Currently a prisoner
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
200 participants (estimated)
Patient registry
No

Groups and cohorts

  • Prospective

    All patients for whom the decision has been made to have the Synergy Disc implanted at participating investigative centers and give informed consent to participate in the prospective segment of this protocol, per country-specific requirements, will be enrolled in the prospective portion of this protocol.

    Device: Synergy Cervical Disc System

  • Retrospective

    Patients who have previously had a Synergy Spine Solutions Synergy Disc implanted will be eligible for inclusion in the retrospective data collection; a waiver of consent, or informed consent, for retrospective data collection from the medical records of the implanting surgeon will be sought per country-specific regulations as applicable.

    Device: Synergy Cervical Disc System

Interventions

  • DeviceSynergy Cervical Disc System

    motion preservation disc

    Also known as: Synergy Disc

06

What researchers measure

Primary outcomes

  1. Neck Disability Index

    \>15 improvement in NDI score (out of 100) in subjects by 12 mo. post operative compared with baseline

    Time frame: 12 months

  2. Device Related or Device Procedure Related Adverse Events

    Absence of major device related adverse events defined as radiographic failure, neurological failure, or failure by adverse event

    Time frame: 12 months

Secondary outcomes

  1. Visual Analog (VAS) pain

    Visual analogue scale (VAS) will be used to evaluate pain where a change of at least 20mm will be considered clinically significant. Neck pain as measured on a 100mm VAS at baseline and at each follow-up time-point. Left and Right arm/shoulder pain as measured on a 100mm VAS at baseline and at each follow-up time-point.

    Time frame: pre-operative and 6 week, 3 months, 6 months, 12 months, annually post operatively

  2. Patient Satisfaction

    patient completed questionnaire on satisfaction with disc replacement surgery

    Time frame: 6 weeks, 3 months, 6 months, 12 months, annually post operatively

  3. Nurick's Criteria

    disease status characterized by physician at each visit

    Time frame: pre-operative and 6 weeks, 3 months, 6 months, 12 months, annually post operatively

  4. Odom's Criteria

    surgical outcome characterized by physician at each post operative visit

    Time frame: 6 weeks, 3 months, 6 months, 12 months, annually post operatively

  5. Neurologic Function

    maintenance or improvement in neurologic status compared to baseline

    Time frame: 6 weeks, 3 months, 6 months, 12 months, annually post operatively

07

Study locations

1 of 1 sites recruiting
  • Spine and Scoliosis Research Associates Australia Ltd
    Windsor, Victoria, Australia
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started May 2022 (actual). Primary completion is estimated for Dec 2030, 103 months after the start.

Of 40 observational studies under Radiculopathy, half reached primary completion within 75 months of starting (the median), counting those still running; a quarter within 26 and three quarters within 95. This study's planned 103 months is above that.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 22, 2022
First posted
Mar 31, 2022
StartActual
May 1, 2022
Primary completionEst.
Dec 2030
CompletionEst.
Dec 2032
Last update
May 8, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 8, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05305430
Lead sponsor
Synergy Spine Solutions
Collaborators
Pacific Clinical Research Group
Responsible party
Sponsor
First posted
Mar 31, 2022
Start date
May 1, 2022
Primary completion
Dec 2030 (estimated)
Completion
Dec 2032 (estimated)
Last update
May 8, 2026

Study contacts

Robyn Capobianco, PhD
Contact
robync@synergyspinesolutions.com
+1-647-692-3493
Christine Nimalasiri
Contact
christine.nimalasiri@pcrg.com.au
Robyn Capobianco, PhD
study director · Sponsor GmbH

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion